PPG
PPH icon

Peak Planning Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Peak Planning Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
9,187
+287
+3% +$29.7K 0.23% 53
2026
Q1 		$925K Buy
8,900
+352
+4% +$37.5K 0.26% 51
2025
Q4 		$882K Buy
+8,548
New +$832K 0.25% 53
2025
Q2 		– Sell
-8,659
Closed -$789K – 121
2025
Q1 		$789K Sell
8,659
-1,415
-14% -$127K 0.33% 51
2024
Q4 		$869K Sell
10,074
-1,695
-14% -$153K 0.36% 50
2024
Q3 		$1.12M Sell
11,769
-489
-4% -$46.4K 0.49% 38
2024
Q2 		$1.12M Buy
12,258
+146
+1% +$13K 0.55% 36
2024
Q1 		$1.1M Buy
12,112
+146
+1% +$12.8K 0.69% 32
2023
Q4 		$974K Sell
11,966
-184
-2% -$14.4K 0.7% 31
2023
Q3 		$970K Sell
12,150
-155
-1% -$12.5K 0.76% 30
2023
Q2 		$969K Buy
12,305
+1,110
+10% +$86.9K 0.72% 32
2023
Q1 		$869K Buy
11,195
+993
+10% +$76.6K 0.71% 35
2022
Q4 		$793K Buy
10,202
+3
+0% +$221 0.7% 35
2022
Q3 		$686K Buy
10,199
+799
+9% +$58.9K 0.63% 37
2022
Q2 		$722K Buy
+9,400
New +$734K 0.61% 36
2021
Q4 		$731K Sell
9,497
-315
-3% -$23.4K 0.54% 37
2021
Q3 		$715K Buy
+9,812
New +$732K 0.61% 35
2021
Q1 		$548K Buy
7,938
+1,356
+21% +$93.4K 0.53% 41
2020
Q4 		$438K Buy
6,582
+351
+6% +$22.5K 0.5% 43
2020
Q3 		$387K Buy
+6,231
New +$394K 0.54% 34

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Peak Planning Group's PPH Position: Q2 2026 in Review

Peak Planning Group increased its VanEck Pharmaceutical ETF (PPH) stake by 3.2% in Q2 2026, buying an estimated $29.7K and bringing the position to 9,187 shares worth $1M. The position accounts for 0.23% of the portfolio, ranked #53.

Peak Planning Group first reported a position in PPH in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.12M in Q2 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Peak Planning Group held 9,187 shares of VanEck Pharmaceutical ETF worth $1M as of Q2 2026.
  • Peak Planning Group bought 287 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $29.7K.
  • VanEck Pharmaceutical ETF made up 0.23% of Peak Planning Group's portfolio in Q2 2026, its #53 holding.
  • Peak Planning Group first reported a position in VanEck Pharmaceutical ETF in Q3 2020 and has held it in 20 quarters since.
  • Peak Planning Group's VanEck Pharmaceutical ETF position peaked at $1.12M in Q2 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Peak Planning Group's 13F filing for Q2 2026, filed 12 Aug 2026.